PARC_NEIGO
ID PARC_NEIGO Reviewed; 768 AA.
AC P48374;
DT 01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT 01-FEB-1996, sequence version 1.
DT 25-MAY-2022, entry version 103.
DE RecName: Full=DNA topoisomerase 4 subunit A {ECO:0000255|HAMAP-Rule:MF_00936};
DE EC=5.6.2.2 {ECO:0000255|HAMAP-Rule:MF_00936};
DE AltName: Full=Topoisomerase IV subunit A {ECO:0000255|HAMAP-Rule:MF_00936};
GN Name=parC {ECO:0000255|HAMAP-Rule:MF_00936};
OS Neisseria gonorrhoeae.
OC Bacteria; Proteobacteria; Betaproteobacteria; Neisseriales; Neisseriaceae;
OC Neisseria.
OX NCBI_TaxID=485;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=MS11;
RX PubMed=7830580; DOI=10.1111/j.1365-2958.1994.tb01297.x;
RA Belland R.J., Morrison S.G., Ison C., Huang W.M.;
RT "Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and
RT parC in fluoroquinolone-resistant isolates.";
RL Mol. Microbiol. 14:371-380(1994).
RN [2]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=MS11;
RA Belland R.J.;
RL Submitted (APR-1994) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: Topoisomerase IV is essential for chromosome segregation. It
CC relaxes supercoiled DNA. Performs the decatenation events required
CC during the replication of a circular DNA molecule. {ECO:0000255|HAMAP-
CC Rule:MF_00936}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP-dependent breakage, passage and rejoining of double-
CC stranded DNA.; EC=5.6.2.2; Evidence={ECO:0000255|HAMAP-
CC Rule:MF_00936};
CC -!- SUBUNIT: Heterotetramer composed of ParC and ParE.
CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000255|HAMAP-Rule:MF_00936};
CC Peripheral membrane protein {ECO:0000255|HAMAP-Rule:MF_00936}.
CC -!- SIMILARITY: Belongs to the type II topoisomerase GyrA/ParC subunit
CC family. ParC type 1 subfamily. {ECO:0000255|HAMAP-Rule:MF_00936}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; U08907; AAA82151.1; -; Genomic_DNA.
DR PIR; S60780; S60780.
DR AlphaFoldDB; P48374; -.
DR SMR; P48374; -.
DR ChEMBL; CHEMBL2363077; -.
DR DrugCentral; P48374; -.
DR GO; GO:0005694; C:chromosome; IEA:InterPro.
DR GO; GO:0019897; C:extrinsic component of plasma membrane; IEA:UniProtKB-UniRule.
DR GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR GO; GO:0003918; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity; IEA:UniProtKB-UniRule.
DR GO; GO:0007059; P:chromosome segregation; IEA:UniProtKB-UniRule.
DR GO; GO:0006265; P:DNA topological change; IEA:UniProtKB-UniRule.
DR CDD; cd00187; TOP4c; 1.
DR Gene3D; 1.10.268.10; -; 1.
DR Gene3D; 2.120.10.90; -; 1.
DR Gene3D; 3.90.199.10; -; 1.
DR HAMAP; MF_00936; ParC_type1; 1.
DR InterPro; IPR035516; Gyrase/topoIV_suA_C.
DR InterPro; IPR013760; Topo_IIA-like_dom_sf.
DR InterPro; IPR013758; Topo_IIA_A/C_ab.
DR InterPro; IPR013757; Topo_IIA_A_a_sf.
DR InterPro; IPR002205; Topo_IIA_dom_A.
DR InterPro; IPR005742; TopoIV_A_Gneg.
DR Pfam; PF00521; DNA_topoisoIV; 1.
DR SMART; SM00434; TOP4c; 1.
DR SUPFAM; SSF101904; SSF101904; 1.
DR SUPFAM; SSF56719; SSF56719; 1.
PE 3: Inferred from homology;
KW Cell membrane; DNA-binding; Isomerase; Membrane; Topoisomerase.
FT CHAIN 1..768
FT /note="DNA topoisomerase 4 subunit A"
FT /id="PRO_0000145403"
FT ACT_SITE 126
FT /note="O-(5'-phospho-DNA)-tyrosine intermediate"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_00936"
FT SITE 46
FT /note="Interaction with DNA"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_00936"
FT SITE 82
FT /note="Interaction with DNA"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_00936"
FT SITE 84
FT /note="Interaction with DNA"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_00936"
FT SITE 125
FT /note="Transition state stabilizer"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_00936"
SQ SEQUENCE 768 AA; 84896 MW; DAD11ECAC172F6EE CRC64;
MNTQPHASHT DSNTLMLGRY AERAYLEYAM SVVKGRALPE VSDGQKPVQR RILFAMRDMG
LTAGAKPVKS ARVVGEILGK YHPHGDSSAY EAMVRMAQDF TLRYPLIDGI GNFGSRDGDG
AAAMRYTEAR LTPIAELLLS EINQGTVDFM PNYDGAFDEP LHLPARLPMV LLNGASGIAV
GMATEIPSHN LNEVTQAAIA LLKKPTLETA DLMQYIPAPD FAGGGQIITP ADELRRIYET
GKGSVRVRAR YEIEKLARGQ WRVIVTELPP NANSAKILAE IEEQTNPKPK AGKKQLNQDR
LNTKKLMLDL IDRVRDESDG EHPVRLVFEP KSSRIDTDTF INTLMAQTSL EGNVSMNLVM
MGLDNRPAQK NLKTILQEWL DFRIVTVTRR LKFRLNQVEK RLHILEGRLK VFLHIDEVIK
VIRESDDPKA DLMAVFGLTE IQAEDILEIR LRQLARLEGF KLEKELNELR EEQGRLNIFL
GDENEKRKLI IKEMQADMKQ FGDARRTLVE EAGRAVLTQT AADEPITLIL SEKGWIRSRA
GHNLDLSQTA FKEGDRLKQT LEGPHCFTRR HPRFIRGRTY SIDAAEIPGG RGDGVPVSSL
IELQNGAKPV AMLTGLPEQH YLLSSSGGYG FIAKLGDMVG RVKAGKVVMT ADSGETVLPP
VAVYASSFIN PDCKIIAATS QNRALAFPIG ELKIMAKGKG LQIIGLNAGE SMTHTAVSSE
PEILIESEGR RGAAHKDRLP VALIEAKRGK KGRLLPISGS LKQLSSPK